In a groundbreaking move aimed at revolutionizing fertility services, Bukit Tinggi Medical Centre (BTMC), KL Fertility Centre, and Amden Capital have announced a strategic partnership. This collaboration is poised to enhance accessibility, quality, and innovation in fertility treatments, marking a significant milestone in the healthcare landscape of the Klang Valley.

KL Fertility Centre, renowned for its excellence in reproductive medicine, will unite forces with BTMC, a leading healthcare institution known for its commitment to patient welfare. The partnership seeks to broaden access to specialized fertility treatments and provide personalized care throughout the fertility journey of patients. Dato’ Dr Prashant Nadkarni, Medical Director of KL Fertility Centre, expressed anticipation for the collaborative opportunities this partnership brings.

“This collaboration expands KL Fertility Centre’s reach, making its high-quality fertility treatments more readily available to patients residing in Klang and its surrounding areas,” remarked Dato’ Dr Prashant Nadkarni. “Eliminating the need for lengthy commutes, this partnership establishes BTMC as a management center, offering a convenient path to parenthood for patients seeking fertility treatment.”

Elevating access and quality

The partnership integrates KL Fertility Centre’s expertise in fertility treatment with BTMC’s commitment to patient care, ensuring access to a comprehensive range of services, including In Vitro Fertilisation (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Egg Freezing (Fertility Preservation), Genetic Testing, and more.

“We are thrilled to partner with BTMC to bring our advanced fertility services closer to the Klang Valley community,” said Dato’ Dr Prashant Nadkarni. “This collaboration allows us to further support patients in their journey towards parenthood and help them realize their dreams of building a family. We are committed to providing exceptional care and achieving the highest success rates possible.”

Commitment to community health

Simultaneously, BTMC has joined hands with Amden Capital to address the financial requirements of patients seeking fertility treatments and other medical services not covered by insurance. Mr. Ranjit Singh, CEO of Amden Capital, highlighted the significance of customized financing solutions in making quality treatment affordable for the masses.

Ms. Jasmine Lau, CEO of BTMC, underscored the hospital’s dedication to providing comprehensive healthcare solutions and meeting the community’s health needs. “By collaborating with KL Fertility Centre, we aim to elevate our services for individuals seeking fertility assistance,” said Lau. “Partnering with Amden Capital will provide additional financing options for patients seeking financial aid in areas such as fertility treatment, dermatology, maternity, and aesthetics.”

With this strategic partnership, BTMC aims to establish new standards of excellence in fertility care, promoting innovation and cooperation to enhance patient outcomes. Leveraging the strengths of each institution, the collaboration is poised to make a significant impact on the lives of individuals and families seeking fertility treatment, fostering hope and empowerment within the community.

The partnership signifies a crucial step forward in addressing the rising demand for quality fertility care in the Klang Valley, reaffirming the commitment of the healthcare sector to meet the evolving needs of the community.


1. Sinchew

2. Citizens Journal

3. Asia Samachar

4. China Press